In the context of breast cancer, high ID4 expression is associated with triple-negative breast cancer (TNBC) and basal-like breast cancer (BLBC) subtypes, where the ID4 gene might be amplified/overexpressed, and marks a subset of cancers with poor prognosis [8,9,10]. The gene discussed is ID4; the disease is triple-negative breast carcinoma.